Reuters logo
Noven Pharmaceuticals gets FDA approvable letter for Stavzor
October 23, 2007 / 10:07 PM / 10 years ago

Noven Pharmaceuticals gets FDA approvable letter for Stavzor

Oct 23 (Reuters) - Noven Pharmaceuticals Inc (NOVN.O) said it received an approvable letter from the U.S. health regulators for its potential treatment for bipolar disorder, migraine and epilepsy. The drugmaker said the U.S. Food and Drug Administration requested certain non-clinical information, as a condition for final approval of Stavzor. Noven said it expects Stavzor to get final approval by the end of July 2008. (Reporting by Esha Dey in Bangalore)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below